Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
29
CCRN Quote, Financials, Valuation and Earnings
Last price:
$7.95
Seasonality move
:
-6.36%
Day range:
$7.89 - $8.05
52-week range:
$7.43 - $18.30
Dividend yield:
0%
P/E ratio:
64.87x
P/S ratio:
0.23x
P/B ratio:
0.64x
Volume:
993.6K
Avg. volume:
1.2M
1-year change:
-55.64%
Market cap:
$260.4M
Revenue:
$1.3B
EPS (TTM):
-$0.48
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CCRN
Cross Country Healthcare, Inc.
|
$270.7M | $0.04 | -17.95% | -48.25% | $9.66 |
|
AGL
Agilon Health, Inc.
|
$1.4B | -$0.13 | -4.03% | -6.74% | $0.97 |
|
AIM
AIM ImmunoTech
|
-- | -$0.09 | -23.08% | -53.85% | $4.50 |
|
CVM
CEL-SCI Corp.
|
-- | -- | -- | -- | $42.50 |
|
HUM
Humana, Inc.
|
$35.4B | $10.64 | 9.8% | -30.6% | $287.83 |
|
IGC
IGC Pharma, Inc.
|
$198K | -$0.02 | -24.9% | -15.25% | $3.88 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CCRN
Cross Country Healthcare, Inc.
|
$7.95 | $9.66 | $260.4M | 64.87x | $0.00 | 0% | 0.23x |
|
AGL
Agilon Health, Inc.
|
$0.73 | $0.97 | $304.5M | -- | $0.00 | 0% | 0.05x |
|
AIM
AIM ImmunoTech
|
$0.04 | $4.50 | $2.8M | -- | $0.00 | 0% | 13.27x |
|
CVM
CEL-SCI Corp.
|
$4.91 | $42.50 | $14.9M | -- | $0.00 | 0% | -- |
|
HUM
Humana, Inc.
|
$259.40 | $287.83 | $31.2B | 24.31x | $0.89 | 1.37% | 0.25x |
|
IGC
IGC Pharma, Inc.
|
$0.30 | $3.88 | $27.9M | -- | $0.00 | 0% | 22.51x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CCRN
Cross Country Healthcare, Inc.
|
0.54% | -1.012 | 0.48% | 3.37x |
|
AGL
Agilon Health, Inc.
|
10.82% | -3.454 | 8.69% | 0.25x |
|
AIM
AIM ImmunoTech
|
48.41% | 0.745 | 17.25% | 0.71x |
|
CVM
CEL-SCI Corp.
|
58.65% | 1.679 | 143.38% | 0.32x |
|
HUM
Humana, Inc.
|
40.5% | 0.632 | 40.21% | 0.00x |
|
IGC
IGC Pharma, Inc.
|
1.82% | 0.805 | 0.39% | 0.78x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CCRN
Cross Country Healthcare, Inc.
|
$46.8M | $806K | -3.74% | -3.76% | 0.32% | $17.9M |
|
AGL
Agilon Health, Inc.
|
-$75.1M | -$127.2M | -65.38% | -71.4% | -8.86% | -$34.7M |
|
AIM
AIM ImmunoTech
|
$27K | -$4.5M | -219.06% | -256.33% | -9994.29% | -$3.3M |
|
CVM
CEL-SCI Corp.
|
-$959K | -$5.5M | -123.39% | -266.61% | -- | -$3.9M |
|
HUM
Humana, Inc.
|
-- | $400M | 4.25% | 7.3% | 0.41% | $836M |
|
IGC
IGC Pharma, Inc.
|
-$6K | -$2.9M | -91.27% | -94.42% | -1517.8% | -$2.4M |
Cross Country Healthcare, Inc. vs. Competitors
-
Which has Higher Returns CCRN or AGL?
Agilon Health, Inc. has a net margin of -1.91% compared to Cross Country Healthcare, Inc.'s net margin of -7.68%. Cross Country Healthcare, Inc.'s return on equity of -3.76% beat Agilon Health, Inc.'s return on equity of -71.4%.
Company Gross Margin Earnings Per Share Invested Capital CCRNCross Country Healthcare, Inc.18.73% -$0.15 $410.3M AGLAgilon Health, Inc.-5.23% -$0.27 $343.2M -
What do Analysts Say About CCRN or AGL?
Cross Country Healthcare, Inc. has a consensus price target of $9.66, signalling upside risk potential of 21.54%. On the other hand Agilon Health, Inc. has an analysts' consensus of $0.97 which suggests that it could grow by 31.38%. Given that Agilon Health, Inc. has higher upside potential than Cross Country Healthcare, Inc., analysts believe Agilon Health, Inc. is more attractive than Cross Country Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CCRNCross Country Healthcare, Inc.0 7 0 AGLAgilon Health, Inc.2 13 0 -
Is CCRN or AGL More Risky?
Cross Country Healthcare, Inc. has a beta of 0.422, which suggesting that the stock is 57.817% less volatile than S&P 500. In comparison Agilon Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CCRN or AGL?
Cross Country Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Agilon Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cross Country Healthcare, Inc. pays -- of its earnings as a dividend. Agilon Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCRN or AGL?
Cross Country Healthcare, Inc. quarterly revenues are $250.1M, which are smaller than Agilon Health, Inc. quarterly revenues of $1.4B. Cross Country Healthcare, Inc.'s net income of -$4.8M is higher than Agilon Health, Inc.'s net income of -$110.2M. Notably, Cross Country Healthcare, Inc.'s price-to-earnings ratio is 64.87x while Agilon Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cross Country Healthcare, Inc. is 0.23x versus 0.05x for Agilon Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCRNCross Country Healthcare, Inc.0.23x 64.87x $250.1M -$4.8M AGLAgilon Health, Inc.0.05x -- $1.4B -$110.2M
-
Which has Higher Returns CCRN or AIM?
AIM ImmunoTech has a net margin of -1.91% compared to Cross Country Healthcare, Inc.'s net margin of -10571.43%. Cross Country Healthcare, Inc.'s return on equity of -3.76% beat AIM ImmunoTech's return on equity of -256.33%.
Company Gross Margin Earnings Per Share Invested Capital CCRNCross Country Healthcare, Inc.18.73% -$0.15 $410.3M AIMAIM ImmunoTech77.14% -$0.06 $5.6M -
What do Analysts Say About CCRN or AIM?
Cross Country Healthcare, Inc. has a consensus price target of $9.66, signalling upside risk potential of 21.54%. On the other hand AIM ImmunoTech has an analysts' consensus of $4.50 which suggests that it could grow by 11066.25%. Given that AIM ImmunoTech has higher upside potential than Cross Country Healthcare, Inc., analysts believe AIM ImmunoTech is more attractive than Cross Country Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CCRNCross Country Healthcare, Inc.0 7 0 AIMAIM ImmunoTech1 0 0 -
Is CCRN or AIM More Risky?
Cross Country Healthcare, Inc. has a beta of 0.422, which suggesting that the stock is 57.817% less volatile than S&P 500. In comparison AIM ImmunoTech has a beta of 0.760, suggesting its less volatile than the S&P 500 by 23.953%.
-
Which is a Better Dividend Stock CCRN or AIM?
Cross Country Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AIM ImmunoTech offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cross Country Healthcare, Inc. pays -- of its earnings as a dividend. AIM ImmunoTech pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCRN or AIM?
Cross Country Healthcare, Inc. quarterly revenues are $250.1M, which are larger than AIM ImmunoTech quarterly revenues of $35K. Cross Country Healthcare, Inc.'s net income of -$4.8M is lower than AIM ImmunoTech's net income of -$3.7M. Notably, Cross Country Healthcare, Inc.'s price-to-earnings ratio is 64.87x while AIM ImmunoTech's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cross Country Healthcare, Inc. is 0.23x versus 13.27x for AIM ImmunoTech. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCRNCross Country Healthcare, Inc.0.23x 64.87x $250.1M -$4.8M AIMAIM ImmunoTech13.27x -- $35K -$3.7M
-
Which has Higher Returns CCRN or CVM?
CEL-SCI Corp. has a net margin of -1.91% compared to Cross Country Healthcare, Inc.'s net margin of --. Cross Country Healthcare, Inc.'s return on equity of -3.76% beat CEL-SCI Corp.'s return on equity of -266.61%.
Company Gross Margin Earnings Per Share Invested Capital CCRNCross Country Healthcare, Inc.18.73% -$0.15 $410.3M CVMCEL-SCI Corp.-- -$1.36 $17M -
What do Analysts Say About CCRN or CVM?
Cross Country Healthcare, Inc. has a consensus price target of $9.66, signalling upside risk potential of 21.54%. On the other hand CEL-SCI Corp. has an analysts' consensus of $42.50 which suggests that it could grow by 765.58%. Given that CEL-SCI Corp. has higher upside potential than Cross Country Healthcare, Inc., analysts believe CEL-SCI Corp. is more attractive than Cross Country Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CCRNCross Country Healthcare, Inc.0 7 0 CVMCEL-SCI Corp.1 0 0 -
Is CCRN or CVM More Risky?
Cross Country Healthcare, Inc. has a beta of 0.422, which suggesting that the stock is 57.817% less volatile than S&P 500. In comparison CEL-SCI Corp. has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.259%.
-
Which is a Better Dividend Stock CCRN or CVM?
Cross Country Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CEL-SCI Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cross Country Healthcare, Inc. pays -- of its earnings as a dividend. CEL-SCI Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCRN or CVM?
Cross Country Healthcare, Inc. quarterly revenues are $250.1M, which are larger than CEL-SCI Corp. quarterly revenues of --. Cross Country Healthcare, Inc.'s net income of -$4.8M is higher than CEL-SCI Corp.'s net income of -$5.7M. Notably, Cross Country Healthcare, Inc.'s price-to-earnings ratio is 64.87x while CEL-SCI Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cross Country Healthcare, Inc. is 0.23x versus -- for CEL-SCI Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCRNCross Country Healthcare, Inc.0.23x 64.87x $250.1M -$4.8M CVMCEL-SCI Corp.-- -- -- -$5.7M
-
Which has Higher Returns CCRN or HUM?
Humana, Inc. has a net margin of -1.91% compared to Cross Country Healthcare, Inc.'s net margin of 0.59%. Cross Country Healthcare, Inc.'s return on equity of -3.76% beat Humana, Inc.'s return on equity of 7.3%.
Company Gross Margin Earnings Per Share Invested Capital CCRNCross Country Healthcare, Inc.18.73% -$0.15 $410.3M HUMHumana, Inc.-- $1.62 $31.2B -
What do Analysts Say About CCRN or HUM?
Cross Country Healthcare, Inc. has a consensus price target of $9.66, signalling upside risk potential of 21.54%. On the other hand Humana, Inc. has an analysts' consensus of $287.83 which suggests that it could grow by 10.96%. Given that Cross Country Healthcare, Inc. has higher upside potential than Humana, Inc., analysts believe Cross Country Healthcare, Inc. is more attractive than Humana, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CCRNCross Country Healthcare, Inc.0 7 0 HUMHumana, Inc.7 16 1 -
Is CCRN or HUM More Risky?
Cross Country Healthcare, Inc. has a beta of 0.422, which suggesting that the stock is 57.817% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.462, suggesting its less volatile than the S&P 500 by 53.84%.
-
Which is a Better Dividend Stock CCRN or HUM?
Cross Country Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.37% to investors and pays a quarterly dividend of $0.89 per share. Cross Country Healthcare, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 35.45% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CCRN or HUM?
Cross Country Healthcare, Inc. quarterly revenues are $250.1M, which are smaller than Humana, Inc. quarterly revenues of $32.6B. Cross Country Healthcare, Inc.'s net income of -$4.8M is lower than Humana, Inc.'s net income of $194M. Notably, Cross Country Healthcare, Inc.'s price-to-earnings ratio is 64.87x while Humana, Inc.'s PE ratio is 24.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cross Country Healthcare, Inc. is 0.23x versus 0.25x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCRNCross Country Healthcare, Inc.0.23x 64.87x $250.1M -$4.8M HUMHumana, Inc.0.25x 24.31x $32.6B $194M
-
Which has Higher Returns CCRN or IGC?
IGC Pharma, Inc. has a net margin of -1.91% compared to Cross Country Healthcare, Inc.'s net margin of -953.4%. Cross Country Healthcare, Inc.'s return on equity of -3.76% beat IGC Pharma, Inc.'s return on equity of -94.42%.
Company Gross Margin Earnings Per Share Invested Capital CCRNCross Country Healthcare, Inc.18.73% -$0.15 $410.3M IGCIGC Pharma, Inc.-3.14% -$0.02 $8.2M -
What do Analysts Say About CCRN or IGC?
Cross Country Healthcare, Inc. has a consensus price target of $9.66, signalling upside risk potential of 21.54%. On the other hand IGC Pharma, Inc. has an analysts' consensus of $3.88 which suggests that it could grow by 1191.67%. Given that IGC Pharma, Inc. has higher upside potential than Cross Country Healthcare, Inc., analysts believe IGC Pharma, Inc. is more attractive than Cross Country Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CCRNCross Country Healthcare, Inc.0 7 0 IGCIGC Pharma, Inc.2 0 0 -
Is CCRN or IGC More Risky?
Cross Country Healthcare, Inc. has a beta of 0.422, which suggesting that the stock is 57.817% less volatile than S&P 500. In comparison IGC Pharma, Inc. has a beta of 0.242, suggesting its less volatile than the S&P 500 by 75.839%.
-
Which is a Better Dividend Stock CCRN or IGC?
Cross Country Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IGC Pharma, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cross Country Healthcare, Inc. pays -- of its earnings as a dividend. IGC Pharma, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCRN or IGC?
Cross Country Healthcare, Inc. quarterly revenues are $250.1M, which are larger than IGC Pharma, Inc. quarterly revenues of $191K. Cross Country Healthcare, Inc.'s net income of -$4.8M is lower than IGC Pharma, Inc.'s net income of -$1.8M. Notably, Cross Country Healthcare, Inc.'s price-to-earnings ratio is 64.87x while IGC Pharma, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cross Country Healthcare, Inc. is 0.23x versus 22.51x for IGC Pharma, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCRNCross Country Healthcare, Inc.0.23x 64.87x $250.1M -$4.8M IGCIGC Pharma, Inc.22.51x -- $191K -$1.8M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
